# OnCo record soligenix (company). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/companies/soligenix/>
  a schema:Organization ;
  onco:kind "company" ;
  schema:identifier "soligenix" ;
  schema:name "Soligenix"@en ;
  schema:alternateName "Soligenix, Inc."@en ;
  schema:description "Soligenix is a New Jersey company developing HyBryte, a synthetic hypericin ointment activated by visible light, for early-stage cutaneous T-cell lymphoma, tested in the phase 3 FLASH trials."@en ;
  schema:url <https://onco.cc/companies/soligenix/>, <https://www.soligenix.com> ;
  schema:dateModified "2026-09-11"^^xsd:date ;
  schema:citation <https://www.soligenix.com>, <https://clinicaltrials.gov/search?lead=Soligenix>, <https://en.wikipedia.org/wiki/Soligenix> ;
  onco:tag "ctgov-sponsor" ;
  schema:addressCountry "US" ;
  onco:sections <https://onco.cc/fronts/radiation/>, <https://onco.cc/fronts/targeted-therapy/> ;
  onco:terms <https://onco.cc/terms/pivotal-trial/>, <https://onco.cc/terms/clinical-trial/> .